Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transforming Ovarian Cancer Diagnostic Pathways (TranSforming Ovarian caNcer diAgnosTic pAthways: A Hybrid Type 1 Effectiveness-implementation Study of a Novel Biomarker Based, Threshold Driven Pathway for Earlier Ovarian Cancer Diagnosis

NCT06129968 is registered in ClinicalTrials.gov with Professor Sudha Sundar as lead sponsor.

NCT NCT06129968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06129968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transforming Ovarian Cancer Diagnostic Pathways (TranSforming Ovarian caNcer diAgnosTic pAthways: A Hybrid Type 1 Effectiveness-implementation Study of a Novel Biomarker Based, Threshold Driven Pathway for Earlier Ovarian Cancer Diagnosis
Lead sponsor
Professor Sudha Sundar
Phase
Observational
Overall status
Recruiting
Start date
January 23, 2024
Completion date
July 31, 2025
Enrollment
34,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer